Weekly Vitals: Tawdry Details About Stryker CEO's Resignation, Hip Implants Showed Early Warning Signs, and More

Posted by Shana Leonard on March 2, 2012

While medical device industry leaders' love lives aren't usually a part of our coverage on Medtech Pulse, we admit we (and everyone else) were intrigued by the Wall Street Journal's article this week positing that Stryker CEO Stephen MacMillan's abrupt resignation last month was tied to some titillating gossip. The WSJ reported that MacMillan's resignation—which was attributed publicly to "family reasons"— came on the heels of board members learning of MacMillan's affair with an ex-employee while he was involved in divorce proceedings. In other news, an e-mail has surfaced indicating that J&J was aware early on of high revision rates and problems with the DePuy ASR all-metal hip implant. The implant was later recalled and subsequent controversy ensued. Read about these and more of the week's top medtech stories in our weekly roundup below.